MOTS-c
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene, discovered by the Cohen lab (USC). It is one of a class of mitochondrial-derived peptides (MDPs) with signaling activity in metabolic homeostasis.
Mechanism
- AMPK activation. Studied for activation of AMP-activated protein kinase, a central metabolic sensor.
- Insulin sensitivity. Preclinical evidence for improved glucose disposal in animal models.
Common research protocols
MOTS-c research protocols are not standardized — no published human RCT has established a dose-response curve, so the ranges below are drawn from the available pharmacokinetic and preclinical literature plus the most consistently cited community research conventions. They are grouped by aggression level so a lower-total-exposure starting point is easy to identify. All administration is subcutaneous.
Evidence at a glance
- Human data. Circulating MOTS-c levels correlate inversely with metabolic dysfunction in observational studies. Exogenous administration is early-stage.
Reconstitution & handling
Lyophilized peptides ship as freeze-dried powder. Reconstitute with bacteriostatic water; refrigerate the reconstituted vial. Use the reconstitution calculator to get syringe-unit readings for your target dose. General reconstitution and syringe guidance in the How We Work page.
Primary-literature list for this guide available on request via contact.
Further reading — external professional sources
- MOTS-c — Wikipedia
- PubMed — search "MOTS-c mitochondrial peptide"
- ClinicalTrials.gov — trials for "MOTS-c"